Our ambition is to change the practice of medicine. To do that we must be citizens of the world, advocating for diversity, equity, and inclusion with our external stakeholders.
Our commitment to social impact is intertwined with our corporate strategy. As a large company with a global footprint, we want to have a positive social impact that goes beyond health and strengthens economic engagement with the communities we serve. That’s why we’re reshaping our supplier spending to include far more diverse communities.
We launched a Global Supplier Diversity Program to increase our inclusion of marginalized communities in our sourcing processes. It’s a springboard for change, helping us expand our networks to include historically disadvantaged and under-represented groups, and challenging our procurement professionals to look beyond the expected. In 2022 we made strides toward our goal of directing €1.5 billion of our procurement spend to small and diverse companies by 2025 (€1.23 billion in 2022).
In 2022 we also published our commitment to double our spend on businesses owned by women (up 33% in 2022 compared to 2021). To accelerate our impact we partnered with WeConnect International, a global network that connects certified women-owned businesses with corporations and the procurement community.